Fermenta Biotech Ltd. engages in the manufacturing and supply of Vitamin D3. The company is headquartered in Thane, Maharashtra. The firm's Bulk drugs/ chemicals segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. Its Property segment includes renting of properties. Its businesses include Vitamin D3 and other active pharmaceutical ingredient's (APIs), nutritional premixes, biotechnology, environmental solutions and real estate. The company produces a range of variants, such as crystalline, oil, resin in oil, cold water dispersible and feed grade powder. The company offers premix solutions for fortifying food. The company provides specialized technologies through enzyme portfolio across biopharmaceutical product lifecycle. The company offers products and services for environmental solutions in wastewater management and treatment.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.